Volume 24, Issue 5 pp. 388-390
Letter to the Editor

Reversal of overdose on fentanyl being illicitly sold as heroin with naloxone nasal spray: A case report

Ayman Fareed MD

Corresponding Author

Ayman Fareed MD

Atlanta VA Medical Center, Decatur, Georgia

Department of Psychiatry, Emory University, Atlanta, Georgia

Address correspondence to Assistant Professor, Fareed, Department of Psychiatry, Emory University, School of Medicine/Staff Psychiatrist, Atlanta VA Medical Center 116A, 1670 Clairmont Rd Decatur, GA 30033.

E-mail: [email protected]

Search for more papers by this author
Ann Marie Buchanan-Cummings MSN, RN

Ann Marie Buchanan-Cummings MSN, RN

Atlanta VA Medical Center, Decatur, Georgia

Search for more papers by this author
Kelli Crampton LCSW

Kelli Crampton LCSW

Atlanta VA Medical Center, Decatur, Georgia

Search for more papers by this author
Angela Grant MSN, RN

Angela Grant MSN, RN

Atlanta VA Medical Center, Decatur, Georgia

Search for more papers by this author
Karen Drexler MD

Karen Drexler MD

Atlanta VA Medical Center, Decatur, Georgia

Department of Psychiatry, Emory University, Atlanta, Georgia

Search for more papers by this author
First published: 03 June 2015
Citations: 15

Abstract

Background

This is a case report describing a reversal of fentanyl overdose with naloxone nasal spray. The patient was not aware that he overdosed on fentanyl being sold as heroin.

Methods

The Veterans Health Administration (VHA) has implemented an initiative to provide education for veterans, their families, friends and significant others about opioid overdose and use of naloxone reversal kits. The Atlanta VA Medical Center adopted this program to reduce the risk of opioid overdose in high risk patients.

Results

Over the past year, we provided educational sessions for 63 veterans and their families. We also prescribed 41 naloxone kits. We have received three reports of opioid overdose reversal with use of naloxone kits prescribed by the Atlanta VA Medical Center.

Conclusions and Scientific significance

The authors recommend that public health administrators and policy makers advocate for the implementation of these programs to reduce the rising number of overdose death in the United States and worldwide. (Am J Addict 2015;24:388 –390)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.